When delays and disruptions threaten not only product integrity but patient well-being, thorough risk assessment and mitigation are essential.
Ilya Preston, PAXAFE
Advertisement
CEO of PAXAFE.
Articles by Ilya Preston, PAXAFE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Pharma Pulse: Mark Cuban Disrupts Drug Pricing, AstraZeneca Expands US Manufacturing, and BMS Bets Big on RNA Therapeutics
2
LogiPharma USA 2025: Challenges Currently Impacting the Temperature-Controlled Space
3
